Simple jQuery Dropdowns

Browsing by Author Sith Sathornsumetee

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)
1-Dec-2007Antiangiogenic therapy in malignant glioma: Promise and challengeSith Sathornsumetee; Jeremy N. Rich; Duke University School of Medicine; Mahidol University
1-Apr-2018Brainstem dysfunction heralding disseminated cryptococcosisPrachaya Srivanitchapoom; Yuvadee Pitakpatapee; Panitta Sitthinamsuwan; Sith Sathornsumetee; Faculty of Medicine, Siriraj Hospital, Mahidol University
1-Jan-2008Designer therapies for glioblastoma multiformeSith Sathornsumetee; Jeremy N. Rich; Mahidol University; Duke University School of Medicine
1-Nov-2007Diagnosis and Treatment of High-Grade AstrocytomaSith Sathornsumetee; Jeremy N. Rich; David A. Reardon; Duke University School of Medicine; Mahidol University
1-Oct-2013Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service.Orasa Chawalparit; Tumtip Sangruchi; Theerapol Witthiwej; Sith Sathornsumetee; Sirion Tritrakarn; Siriwan Piyapittayanan; Prapaluck Chaicharoen; Thanyaporn Direksunthorn; Panida Charnchaowanish; Mahidol University
1-Feb-2018Effect of spinal tap test on the performance of sit-to-stand, walking, and turning in patients with idiopathic normal pressure hydrocephalusSunee Bovonsunthonchai; Theerapol Witthiwej; Chanon Ngamsombat; Sith Sathornsumetee; Roongtiwa Vachalathiti; Weerasak Muangpaisan; Pichaya Hengsomboon; Suthasinee Thong-On; Supattra Jankhum; Pusanisa Yangyoo; Mahidol University; Faculty of Medicine, Siriraj Hospital, Mahidol University
1-Feb-2010Medical oncology: Treatment and management of malignant gliomasDeric M. Park; Sith Sathornsumetee; Jeremy N. Rich; University of Pittsburgh Cancer Institute; Mahidol University; Cleveland Clinic Foundation
12-Jan-2012Molecularly targeted therapy in neuro-oncologySith Sathornsumetee; Jeremy N. Rich; Mahidol University; Cleveland Clinic Foundation
1-Mar-2012Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patientsDavid A. Reardon; James E. Herndon; Katherine Peters; Annick Desjardins; April Coan; Emil Lou; Ashley Sumrall; Scott Turner; Sith Sathornsumetee; Jeremy N. Rich; Susan Boulton; Eric S. Lipp; Henry S. Friedman; James J. Vredenburgh; Dana-Farber Cancer Institute; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation
1-Jan-2017P40: Gait alteration in patients with Idiopathic Normal Pressure Hydrocephalus after cerebral spinal fluid removalSunee Bovonsunthonchai; Theerapol Witthiwej; Chanon Ngamsombat; Sith Sathornsumetee; Roongtiwa Vachalathiti; Mahidol University
1-Jul-2012Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant gliomaDavid A. Reardon; James J. Vredenburgh; Annick Desjardins; Katherine B. Peters; Sith Sathornsumetee; Stevie Threatt; John H. Sampson; James E. Herndon; April Coan; Frances McSherry; Jeremy N. Rich; Roger E. McLendon; Steven Zhang; Henry S. Friedman; Dana-Farber Cancer Institute; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation; Bristol-Myers Squibb
1-Dec-2011Phase i study of sunitinib and irinotecan for patients with recurrent malignant gliomaDavid A. Reardon; James J. Vredenburgh; April Coan; Annick Desjardins; Katherine B. Peters; Sridharan Gururangan; Sith Sathornsumetee; Jeremy N. Rich; James E. Herndon; Henry S. Friedman; Duke University School of Medicine; Mahidol University; Cleveland Clinic Foundation
1-Oct-2012Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade gliomaDavid A. Reardon; Annick Desjardins; James J. Vredenburgh; James E. Herndon; April Coan; Sridharan Gururangan; Katherine B. Peters; Roger McLendon; Sith Sathornsumetee; Jeremy N. Rich; Eric S. Lipp; Dorothea Janney; Henry S. Friedman; Duke University; Mahidol University; Cleveland Clinic Foundation
1-Dec-2010Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant gliomaSith Sathornsumetee; Annick Desjardins; James J. Vredenburgh; Roger E. McLendon; Jennifer Marcello; James E. Herndon; Alyssa Mathe; Marta Hamilton; Jeremy N. Rich; Julie A. Norfleet; Sridharan Gururangan; Henry S. Friedman; David A. Reardon; Duke University School of Medicine; Cleveland Clinic Foundation; Mahidol University; OSI Pharmaceuticals Inc.
1-Feb-2012Siriraj Acute Stroke Unit: 10 years experience.Songchai Chinwatanakul; Kanokwan Boonyapisit; Darakul Pornsriniyom; Naraporn Proyoonwiwat; Vorapan Senanarong; Rungsan Chaisevikul; Chotipat Danchaivijitr; Watanachai Chotinaiwatarakul; Sith Sathornsumetee; Niphon Poungvarin; Mahidol University
1-Mar-2009Targeting multiple kinases in glioblastoma multiformeSith Sathornsumetee; David A. Reardon; Duke University School of Medicine; Mahidol University
1-Nov-2016Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesisTanwarat Sanvoranart; Aungkura Supokawej; Pakpoom Kheolamai; Yaowalak U-pratya; Niphon Poungvarin; Sith Sathornsumetee; Surapol Issaragrisil; Mahidol University; Faculty of Medicine, Thammasat University
8-Sep-2015Teaching Neuro Images: Erdheim-Chester disease (polyostotic sclerosing histiocytosis)Prachaya Srivanitchapoom; Sith Sathornsumetee; Mahidol University
1-Jan-2011Therapeutic strategies to target multiple kinases in glioblastomaSith Sathornsumetee; Mahidol University
1-Nov-2011Twisted tango: Brain tumor neurovascular interactionsAnita B. Hjelmeland; Justin D. Lathia; Sith Sathornsumetee; Jeremy N. Rich; Cleveland Clinic Foundation; Mahidol University; CASE School of Medicine